References
- Kukla M, Berdowska A, Stygar D, Gabriel A, Mazur W, Logiewa-Bazger B, Serum FGF21 and RBP4 levels in patients with chronic hepatitis C. Scand J Gastroenterol 2012: in press.
- Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf) 2009;71:369–75.
- Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010;139:456–63.